Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1998
03/18/1998CN1176101A N -(4 -aryl -thiazol -2 -yl) -sulphonamide derivatives and their use
03/18/1998CN1037773C Heteroatoms-containing tricyclic compounds
03/18/1998CN1037770C Method for preparing substituted thiazolyl and substituted pyridinyl derivatives
03/17/1998US5728868 Prodrugs of protein tyrosine kinase inhibitors
03/17/1998US5728846 Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
03/17/1998US5728845 Immunotherapeutic nitriles
03/17/1998US5728844 Immunotherapeutic agents
03/17/1998US5728819 Secreted proteins and polynucleotides encoding them
03/17/1998US5728739 Ligands with affinity for retinoic acid receptors in synergistic combination with a fatty acid, treatment of diabetes, cardiovascular disease, atherosclerosis
03/17/1998US5728716 Trachykinin peptide for nervous system disorders and cardiovascular disorders
03/17/1998US5728686 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals
03/17/1998US5728684 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
03/17/1998US5728679 BMP-15 compositions
03/17/1998US5728676 Use of insulin-like growth factors I and II for inhibition of inflammatory response
03/17/1998US5728392 Cosmetic and/or dermatological composition for the treatment of aging, containing ceramides, and the use thereof
03/17/1998US5728378 Antitumor and antivirus agents
03/16/1998CA2215655A1 Use of 8,9-dehydroestrone as an estrogen with neutral effects on prolactin levels
03/12/1998WO1998010085A2 Gene therapy for congestive heart failure
03/12/1998WO1998010071A1 Angiogenic factor and use thereof in treating cardiovascular disease
03/12/1998WO1998010068A2 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998WO1998010066A1 Modulators of brca1 activity
03/12/1998WO1998009993A1 Novel protease inhibitors derived from guamerin
03/12/1998WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS
03/12/1998WO1998009980A1 Bh3 interacting domain death agonist
03/12/1998WO1998009977A1 Tetrahydronapthalene derivatives and their therapeutic use
03/12/1998WO1998009975A1 1,3-dicarboxylic germanium complex and its therapeutic use
03/12/1998WO1998009961A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998WO1998009957A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/12/1998WO1998009953A2 Azinyloxy-and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed eta/etb endothelin receptor antagonists
03/12/1998WO1998009946A1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
03/12/1998WO1998009940A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
03/12/1998WO1998009934A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998WO1998009630A1 Compounds and methods
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1998009625A1 SELECTIVE β3 ADRENERGIC AGONISTS
03/12/1998WO1998009620A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-λB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
03/12/1998WO1998009618A2 Graft survival prolongation with porphyrins
03/12/1998WO1998009533A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998WO1998005792A3 A novel human leptin receptor gene-related protein
03/12/1998WO1998004709A3 Herpes simplex virus ICP4 is an inhibitor of apoptosis
03/12/1998WO1998001563A3 Adenovirus e4 proteins for inducing cell death
03/12/1998WO1997046682A3 Polynucleotides from human adult PBMC encoding secreted proteins
03/12/1998WO1997040854A3 Polypeptide conjugates for transporting substances across cell membranes
03/12/1998DE19636769A1 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung 3-substituted pyrido [4 ', 3': 4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use
03/12/1998DE19636150A1 N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung N-substituted indole-3-glyoxylamides with anti-asthmatic, anti-allergic and immunosuppressive / immunomodulatory effect
03/12/1998DE19636046A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten New carboxylic acid derivatives, their preparation and use as a mixed ET¶A¶ / ET¶B¶ receptor antagonists
03/12/1998CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998CA2265504A1 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed eta/etb endothelin receptor antagonists
03/12/1998CA2264965A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998CA2264942A1 Compounds and methods
03/12/1998CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998CA2264737A1 Tetrahydronaphthalene derivatives and their therapeutic use
03/12/1998CA2264654A1 1,3-dicarboxylic germanium complex and its therapeutic use
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2259959A1 Modulators of brca1 activity
03/12/1998CA2256716A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998CA2256631A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/12/1998CA2234886A1 Graft survival prolongation with porphyrins
03/11/1998EP0828005A2 Apoptotic agents for tumor cells of the nervous system
03/11/1998EP0828003A2 Human serine protease
03/11/1998EP0827959A2 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
03/11/1998EP0827746A1 Carbazole analogues as selective B3 adrenergic agonists
03/11/1998EP0827744A2 Use of amino acids for the manufacture of a medicament for inhibiting or activating glutamic acid in the brain
03/11/1998EP0827743A1 Use of histone decarboxylase inhibitors for treating fibrosis
03/11/1998EP0827742A1 Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
03/11/1998EP0827546A2 Gene therapy using replication competent targeted adenoviral vectors
03/11/1998EP0827544A2 Multimeric proteins
03/11/1998EP0827539A2 Kunitz type protease inhibitors
03/11/1998EP0827538A1 Novel variants of apolipoprotein a-i
03/11/1998EP0827404A1 Combination of methotrexate and tenidap for the treatment of rheumatoid arthritis
03/11/1998EP0827403A1 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors
03/11/1998EP0827401A2 Methods and compositions for inhibiting alpha-reductase activity
03/11/1998EP0827399A1 Inhibiting photodecomposition of 3-substituted-2-oxindoles
03/11/1998EP0827392A1 Cosmetic or dermatological preparations containing phytic acid
03/11/1998EP0786997A4 Muscarine antagonists
03/11/1998EP0785933B1 Indole derivatives as 5ht1-like agonists
03/11/1998EP0705257B1 Aminoacid derivatives as no synthase inhibitors
03/11/1998EP0663902B1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
03/11/1998EP0636125B1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
03/11/1998CN1175944A 1 -aryl -2 -acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
03/11/1998CN1175903A Method of treating adenosine depletion
03/11/1998CN1175887A Amino acid composition and use thereof in clinical nutrition
03/11/1998CN1175573A Vitamin D3 analogs
03/11/1998CN1175465A Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
03/11/1998CN1175463A Anti-senility hypolipemic Chinese medicine liquor
03/11/1998CN1175410A S -alkyl -DL -homocysteine -S, R -sulfinyl imine medicine
03/10/1998US5726313 Substituted arylaliphatic compounds, method of preparing them and pharmaceutical compositions in which they are present
03/10/1998US5726305 Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
03/10/1998US5726302 Water soluble adenosine kinase inhibitors
03/10/1998US5726291 Amylase inhibitors
03/10/1998US5726290 Soluble analogues of integrins
03/10/1998US5726205 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
03/10/1998US5726200 Treatment of obesity, gastrointestinal disorders, tumors, drug withdrawal; useful as antipsychotic, antianxiety, antiulcer agents;
03/10/1998US5726196 Aromatase-inhibiting composition containing azole derivative
03/10/1998US5726194 Endothelin receptor antagonists
03/10/1998US5726191 Aromatic carboxylic acid esters
03/10/1998US5726184 Tetralin compounds with improved MDR activity
03/10/1998US5726177 Indole-derived arylpiperazines as ligands for 5HT1 -like, 5HT1B and 5HT1D receptors
1 ... 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 ... 1564